SEC 13F Intelligence

Temasek Holdings (Private) Ltd / ONC

Temasek Holdings (Private) Ltd’s Beone Medicines Ltd Position

Does Temasek Holdings (Private) Ltd own Beone Medicines Ltd (ONC)? Yes — 862.6K shares worth $256M (+0.84% of its 13F portfolio) as of Q1 2026, down from 919.6K shares the prior filed quarter.

Position Value
$256M
Q1 2026
Shares
862.6K
% of Portfolio
+0.84%
Quarters Held
30
currently held

Position History ONC

Reported value by quarter
Q4 ’18: $318MQ4 ’18Q1 ’19: $300MQ2 ’19: $281MQ3 ’19: $278MQ4 ’19: $376MQ4 ’19Q1 ’20: $301MQ2 ’20: $499MQ3 ’20: $759MQ4 ’20: $685MQ4 ’20Q1 ’21: $956MQ2 ’21: $943MQ3 ’21: $943MQ4 ’21: $801MQ4 ’21Q1 ’22: $559MQ2 ’22: $480MQ3 ’22: $419MQ4 ’22: $684MQ4 ’22Q1 ’23: $419MQ2 ’23: $536MQ3 ’23: $542MQ4 ’23: $544MQ4 ’23Q1 ’24: $471MQ2 ’24: $430MQ3 ’24: $536MQ4 ’24: $282MQ4 ’24Q1 ’25: $270MQ2 ’25: $245MQ3 ’25: $345MQ4 ’25: $279MQ4 ’25Q1 ’26: $256Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026862.6K$256M+0.84%
Q4 2025919.6K$279M+0.88%
Q3 20251.01M$345M+1.19%
Q2 20251.01M$245M+0.94%
Q1 2025993.8K$270M+1.09%
Q4 20241.53M$282M+1.11%
Q3 20242.39M$536M+2.17%
Q2 20243.01M$430M+2.00%
Q1 20243.01M$471M+2.61%
Q4 20233.01M$544M+3.04%
Q3 20233.01M$542M+3.23%
Q2 20233.01M$536M+3.11%
Q1 20233.11M$419M+2.51%
Q4 20223.11M$684M+4.00%
Q3 20223.11M$419M+2.50%
Q2 20222.97M$480M+2.62%
Q1 20222.97M$559M+2.36%
Q4 20212.96M$801M+2.89%
Q3 20212.75M$943M+3.16%
Q2 20212.75M$943M+2.75%
Q1 20212.75M$956M+3.75%
Q4 20202.65M$685M+2.94%
Q3 20202.65M$759M+3.85%
Q2 20202.65M$499M+2.98%
Q1 20202.45M$301M+2.22%
Q4 20192.27M$376M+2.46%
Q3 20192.27M$278M+2.04%
Q2 20192.27M$281M+2.01%
Q1 20192.27M$300M+2.07%
Q4 20182.27M$318M+2.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Temasek Holdings (Private) Ltd’s full portfolio or all institutional holders of ONC.